Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In most states, phone calls or video chats are not required
CagriSema (Cagrilintide + Semaglutide) CagriSema is a co-formulated combination therapy containing 2.4 mg each of Cagrilintide (a long-acting amylin analog) and Semaglutide (a GLP-1 receptor agonist), administered as a single weekly subcutaneous injection
Enhanced Joint Function Patients often report smoother movement, less stiffness, and reduced joint pain making it popular among active adults and those managing arthritis
But these aren't approved medical uses
US$ 28.45
US$ 22.16
US$ 29.12
US$ 25.50
US$ 24.57
US$ 25.59
US$ 29.37
US$ 29.74
